Asha Palat and Brandon Mistretta, Ph.D. students at the University of Houston, are exploring innovative cancer treatments by manipulating cell signaling to halt tumor growth. Utilizing FastSelect RNA Removal Kits and advanced next-generation sequencing (NGS) techniques, their work aims to forge more humane and effective cancer therapies.
I don’t have a lot of cells remaining at the end of the experiment. So it’s important that the kit is good at extracting the RNA from a limited sample size. I found that QIAGEN Kits are great for this kind of extraction, and the quality of the RNA extracted is great as well.
Asha Palat, University of Houston's Department of Biology and Biochemistry
QIAseq FastSelect has really been phenomenal with the RNA sequencing in my project. The RNA was degraded and almost unusable, but QIAseq FastSelect really removes the ribosomal RNA in these degraded samples and has improved our sequencing libraries.
Brandon Mistretta, University of Houston’s Department of Biology and Biochemistry
By combining both of our approaches, the tumor environment is now more hospitable, and the immune cells are now equipped with the means to actually infiltrate into the tumor.
Asha Palat, University of Houston's Department of Biology and Biochemistry
September 2019 (Updated 2024)